KLRS - Allovir, Inc.
9.82
0.145 1.477%
Share volume: 41,326
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$9.68
0.14
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-09-2024 | 11-12-2024 | 03-07-2025 | 05-14-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 22.835 M | 7.262 M | 5.637 M | 19.522 M | 10.354 M | 12.741 M | |
| Selling general and admin | 10.662 M | 7.169 M | 5.883 M | 19.202 M | 4.324 M | 3.615 M | |
| Research and development | 12.173 M | 93.000 K | -246.000 K | 320.000 K | 6.030 M | 9.126 M | |
| Total expenses | 32.299 M | 7.774 M | 5.720 M | 19.648 M | 10.354 M | 12.741 M | |
| -75.93% | -26.42% | 243.50% | -47.30% | 23.05% | |||
| Operating income | -32.299 M | -7.774 M | -5.720 M | -19.648 M | -10.354 M | -12.741 M | |
| Ebit | -31.545 M | -7.436 M | -5.620 M | -19.654 M | -10.161 M | -11.894 M | |
| Pretax income | -30.299 M | -6.076 M | -4.126 M | -18.268 M | -10.161 M | -11.894 M | |
| -79.95% | -32.09% | 342.75% | -44.38% | 17.06% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -30.299 M | -6.076 M | -4.126 M | -18.268 M | -10.196 M | -11.894 M | |
| 79.95% | 32.09% | -342.75% | 44.19% | -16.65% |